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During tissue homeostasis, normal stem cells self-renew and repopulate the diverse cell
types found within the tissue via a series of carefully controlled symmetric and asymmetric
cell divisions (ACDs). The notion that solid tumors comprise a subset of cancer stem cells
(CSCs) with dysregulated self-renewal and excessive symmetric cell divisions has led to
numerous studies aimed to elucidate the mechanisms regulating ACD under steady-state
conditions, during stem-cell expansion and in cancer. In this perspective, we focus on a
type of asymmetry that can be established during ACD, called non-random co-segregation
of template DNA, which has been identified across numerous species, cell types, and
cancers. We discuss the role of p53 loss in maintaining self-renewal in both normal and
malignant cells. We then review our current knowledge of the mechanisms underlying
co-segregation of template DNA strands and the stem-cell pathways associated with it in
normal and CSCs.




The continual maintenance of a reservoir of tissue-specific stem
cells affords an organism with the ability to generate all the differ-
entiated cells needed for tissue homeostasis and repair through-
out its lifespan. During homeostasis or repair, a stem cell can
undergo asymmetric cell division (ACD) to simultaneously gen-
erate daughters with differing cell fates. One daughter remains a
stem cell and the other gives rise to differentiated progeny that
carry out the functions of the mature tissue. When a stem cell
asymmetrically divides, it does so by actively segregating one or
more intrinsic cell fate-determining constituents, or by polariz-
ing the cell cortex and aligning the mitotic spindle so that the
two daughter cells are exposed to differing external stimuli direct-
ing their cell fate potential (1, 2). In certain circumstances, such
as during development or after stem cell depletion from exces-
sive injury, normal stem cells can also be exponentially expanded
through a series of symmetric divisions. Thus, both asymmetric
and symmetric cell divisions can lead to stem cell self-renewal.
ASYMMETRIC CELL DIVISION IN CANCER
It is necessary to maintain a tightly controlled balance between
symmetric and asymmetric stem cell divisions in order to preserve
an optimal number of stem cells within a tissue or organ. When the
balance is shifted to favor excessive symmetric self-renewing divi-
sions, it can lead to a hyperplastic state and cancer development
[reviewed in Ref. (3)]. The tumor itself, however, can be viewed as
an abnormal organ in which the mature tumor cells are seeded in
a hierarchical fashion by a stem cell-like population, called cancer
stem cells (CSCs). Unlike normal stem cells, CSCs have lost the
ability to control their mode of cell division, resulting in continual
excessive symmetric cell divisions and consequential uncontrolled
tumor growth (Figure 1).
A debated question in CSC biology is whether neoplastic trans-
formation emerges from normal stem/progenitor cells or from
more differentiated cells that commandeer stem cell properties
during or after the oncogenic process. Since normal stem cells
inherently possess many of the properties that CSCs exploit,
it seems more likely that a tumor would arise from a normal
stem cell. Lineage tracing experiments and genetically engineered
mouse models in which oncogenic events were restricted to spe-
cific cell types have confirmed that transformation can indeed
arise from the normal stem cell population (4). However, several
reports have demonstrated that certain progenitor and differen-
tiated cells can also be transformed [reviewed in Ref. (5)]. Thus,
tumors comprise a hierarchically organized cell population seeded
by CSCs regardless of the cell of origin. Notwithstanding, uncov-
ering the mechanisms regulating normal stem cell self-renewing
divisions could provide insights into how those mechanisms are
disrupted in CSC biology, and lead to pharmacological strategies
to deplete the CSC pool altogether.
Another intriguing feature in stem cell biology is cellular plas-
ticity. It was long believed that tissues were hierarchically organized
in which the tissue-specific stem cells reside at the apex and dif-
ferentiation could only occur in one direction. However, recent
in vivo lineage tracing experiments have proved that differenti-
ated cells within a tissue can replenish the stem cell population (6,
7), especially after an event that induces stem-cell depletion. Our
new understanding of normal cellular plasticity lends credence
to the argument that cancer cells can dedifferentiate into CSCs.
A normal stem cell or CSC that arises from a more differenti-
ated cell would theoretically repossess the ability to symmetrically
www.frontiersin.org August 2014 | Volume 4 | Article 226 | 1
Pine and Liu Asymmetric cell division in CSCs
FIGURE 1 | Solid tumors are fueled by cancer stem cells undergoing
excessive symmetric cell divisions. (A) A normal stem cell maintains
tissue homeostasis by self-renewing and providing the differentiated cell
types within the tissue through a controlled series of symmetric and
asymmetric cell divisions. (B) A cancer stem cell fuels uncontrolled tumor
growth when it undergoes excessive symmetric cell divisions due to
dysregulated self-renewal.
or asymmetrically divide. How cellular plasticity might affect
genomic integrity, proliferative lifespan of the resultant stem cell,
or organismal aging is unknown.
CO-SEGREGATION OF TEMPLATE DNA STRANDS
One of the most intriguing types of asymmetry during ACD is the
active segregation of the “older” template DNA strands specifically
to one daughter cell and the shunting of the newly synthesized
DNA strands to the other. As elegantly recounted by K. Gordon
Lark in the research topic on stem cell genetic fidelity (8), the
discovery of template DNA strand co-segregation during cell divi-
sion resulted from a series of experiments in the mid to late 1960s
(9). Even though it has been observed across numerous species
and tissue types, the notion of template DNA co-segregation has
been debated extensively because of a failure to observe it in some
tissue stem cells, which might have been caused in some cases
by the differing methods utilized to detect it [reviewed in Ref.
(10)]. The initial observations by Lark led to theories explaining
why cells would actively sort their DNA into old and new strands
during cell division. One explanation, called the “immortal DNA
strand hypothesis,” states that stem cells prevent cancer-causing
replication-induced DNA mutations by exclusively co-segregating
their older, “immortal” DNA strands to the long-lived daughter
stem cells and passing their newly synthesized DNA off to the
daughter cells that give rise to differentiated cells (11).
An alternative though not mutually exclusive hypothesis
explains that the older template DNA strands harbor epigenetic
marks that differ from those on the newer DNA strands. The dif-
fering epigenetic tags direct differential gene expression after cell
division, leading to differing fates of the daughter cells. If the older
versus newer sets of sister chromatids harbor differing epigenetic
marks, it is likely that the tags are added during DNA synthesis,
though this has not been definitively tested (12). The most con-
vincing evidence supporting this hypothesis is from Amar Klar’s
group, in which they demonstrated that specific sister chromatids
are segregated during ACD in Caenorhabditis elegans and mice
(13–15), which was based from their studies performed on the
fission yeast Schizosaccharomyces pombe. Yeast sister cells develop-
mentally differed by inheriting sister chromatids that were differ-
entiated by epigenetic differences [reviewed in Ref. (16)]. While
neither the immortal strand hypothesis nor epigenetic changes
have been proven to be the driving functional consequence of co-
segregation of template DNA strands in multicellular organisms;
preservation of genomic integrity and gene expression patterns
prior to stem cell division would both be beneficial to stem cell
and organismal survival.
TEMPLATE DNA STRAND CO-SEGREGATION IN CANCER
In addition to normal tissues, we and others have found evi-
dence for template DNA strand co-segregation in cell lines and
short-term cultures of human tumors from numerous cancer
types (17–22). It is unknown if the retention of template DNA
co-segregation in cancer cells is a passive, albeit dysregulated,
remnant of hierarchical organization in normal tissues, or if it
offers a survival advantage. The mutation theory of the immor-
tal DNA strand hypothesis is far more relevant in normal stem
cells compared to malignant cells, because genomic instability and
consequential tumor progression would be favored for tumor cell
survival. But epigenetic regulation plays a central role in tumor
progression (23), so priming the daughter cells with an epigenetic
signature prior to cell division could potentially accelerate tumor
progression.
We reported that the frequency of template DNA co-
segregation in lung and breast cancer cell lines decreases when
the microenvironment favors symmetric self-renewal (17, 18),
and that the template DNA strands are inherited by the daugh-
ter cell with more CSC-like qualities (17). Therefore, it is likely
that the mechanism underlying the decision to self-renew is an
active process at least partly under the control of extrinsic factors.
Elucidation of the molecular mechanisms driving template DNA
strand co-segregation in cancer would provide important clues for
why and how CSCs undergo excessive self-renewal.
p53 IN ASYMMETRIC CELL DIVISION AND TEMPLATE DNA
STRAND CO-SEGREGATION
LOSS OF p53 DURING STEM CELL SELF-RENEWAL
p53 is the most extensively studied tumor suppressor gene and is
often referred to as the “guardian of the genome” (24). The best
understood functions of p53 are in the orchestration of cellular
responses to different stress stimuli through the induction of cell
cycle arrest, DNA repair, senescence, and apoptosis. Recently, p53
was found to function in the maintenance of a stem cell state. Work
that has emerged from reprograming somatic cells into pluripotent
cells, referred to as induced pluripotent stem cells (iPSCs), has con-
firmed the role of the p53 pathway in the production of this type
of stem cell. Loss or knockdown of p53 not only increases repro-
graming efficiency, it also accelerates the kinetics of reprograming
[reviewed in Ref. (25)], though it is not yet clear exactly how loss of
p53 contributes to improved reprograming efficiency. There has
Frontiers in Oncology | Cancer Genetics August 2014 | Volume 4 | Article 226 | 2
Pine and Liu Asymmetric cell division in CSCs
been mounting evidence that loss of p53 contributes to normal
stem cell self-renewal, especially after DNA damage. An excellent
example supporting this comes from work on mammary epithelial
and hematopoietic stem cells. Pier Pelicci’s group demonstrated
that unlike progenitor and differentiated cells that activate p53 in
response to DNA damage, p53 is not activated in normal stem cells.
Intriguingly, p53-independent upregulation of p21 in normal stem
cells after DNA damage inhibits p53 activity and shifts the cell divi-
sions from asymmetric to symmetric self-renewal (26). Given the
central role of p53 in normal stem cell self-renewal, and the con-
jecture that cancer is a disease of excessive self-renewal, it stands
to reason that p53 mutations may induce excessive self-renewal
of CSCs. Loss of p53 resulted in the expansion of pre-malignant
mammary stem cells through increased symmetric self-renewing
divisions, and when p53 was reactivated, there was a reduction in
the CSC pool due to restoration of ACDs (27). Thus p53 likely
plays a direct and central role in regulating the switch between
asymmetric and symmetric cell divisions of both normal stem
cells and CSCs.
p53 IN ASYMMETRIC CELL DIVISION
Sherley’s group demonstrated that, in cell lines derived from
murine embryonic fibroblasts and mammary epithelial cells,
expression of wildtype p53 at physiological levels shifted the bal-
ance from symmetric to asymmetric stem cell kinetics. In this
system, asymmetric self-renewal was defined as a cell giving rise
to a stem-like cycling cell and a non-dividing daughter cell (28).
Expression of p53 also altered co-segregation of template DNA.
Under conditions that favored symmetric self-renewal in which
p53 was not expressed, chromosomes were randomly segregated
during cell division. In contrast, expression of p53, which favored
asymmetric self-renewal, induced a shift toward increased co-
segregation of template DNA strands (28). Thus, p53 induces
asymmetric self-renewal of adult stem cells not only at a functional
but also at a genomic level. These data support the notion that
asymmetric self-renewal and template DNA strand co-segregation
are at least sometimes coupled in stem cells.
THE ROLE OF DNA DAMAGE IN ASYMMETRIC CELL DIVISION
After a tissue damaging event, a large number of stem cells would
be needed to quickly respond, expand, and replace damaged
cells. However, cells could be most vulnerable to DNA replica-
tion errors during hyperproliferation and tissue regeneration. The
fact that the genome would actively symmetrically segregate its
damaged DNA to both daughter stem cells during rapid expan-
sion seems counter-intuitive. According to the “immortal” DNA
strand hypothesis, stem cells avoid passing their nascent DNA
strands, wrought with potential DNA replication errors, off to
its daughter stem cell while co-segregating its older and presum-
ably undamaged DNA to its daughter stem cell. Why then would
stem cells symmetrically self-renew and risk passing replication
errors off to the daughter stem cells during a time of rapid cell
cycling? An assumption of the “immortal” DNA strand hypothe-
sis is that stem cell DNA segregation is under normal steady-state
conditions. Perhaps when faced with a DNA damaging event and
expansion of the stem cell pool is necessary to regenerate lost
cells, the symmetrically self-renewing stem cells employ an as yet
undiscovered DNA damage response pathway unique to repair-
ing the stem cell genome. Based on the work from Pelicci’s group
as described above, the pathway is likely to be independent of
p53. Furthermore, mouse embryonic stem cells (ESCs) undergo
repair double strand breaks much faster than differentiated cells,
primarily using homologous recombination [reviewed in Ref.
(29)]. Given that reduction of p53 supports replication-associated
homologous recombination, it is possible that this DNA repair
pathway prevails in symmetrically dividing somatic stem cells,
though this would need to be tested. A stem cell-associated DNA
repair pathway would also complement Cairn’s original obser-
vations in which he found a mathematical discrepancy between
predicted DNA mutation rates in human tissue cells and human
cancer incidence (11). Furthermore, it was proposed that chemi-
cal modifications or DNA mutations in the “immortal” stem cell
genome contributes to aging (30). Together with co-segregation
of template DNA strands, such a DNA repair mechanism dur-
ing symmetric self-renewal would protect the stem cell genome
from not only DNA replication errors but also DNA damage, and
possibly even the cellular aging process.
p53 ISOFORMS
We would be remiss to discuss the central role of p53 in stem cell
ACD without mentioning p53 isoforms. The human TP53 gene
encodes at least 13 isoforms that are the result of alternative splic-
ing or alternative promoters (31). Two of the best studied human
p53 isoforms functionally interact with full-length p53. Isoform
∆133p53 is an N-terminally truncated isoform that inhibits full-
length p53 in a dominant-negative manner. Isoform p53β is a
C-terminally truncated isoform that cooperates with full-length
p53 (32). Curtis Harris’ group, with whom Sharon R. Pine had her
post-doctoral fellowship training, demonstrated that p53 isoform
switching can modulate the youthfulness of a cell. They showed
that p53β represses and ∆133p53 increases the replicative lifes-
pan of normal human fibroblasts cultured in vitro. Furthermore,
p53 isoform switching was associated with tumor progression in
colon cancer (33), consistent with the modes of functional interac-
tion between these p53 isoforms and full-length p53. They further
demonstrated that p53 isoform switching directly modulates cel-
lular replicative lifespan, senescence, and activation of CD8+ T
lymphocytes in vivo (34). An untested question to date is whether
p53 isoforms are associated with ACD. This could have important
implications in cancer biology because p53 isoform expression
patterns and activity would theoretically depend on the location
of the TP53 mutation. We did not observe a correlation between
p53 mutation or deletion status and frequency of template DNA
asymmetric segregation in a panel of breast cancer cell lines (18).
It would be intriguing to test if specific p53 isoforms are involved
in the regulation ACD or co-segregation of template DNA strands.
MOLECULAR MECHANISMS OF TEMPLATE DNA STRAND
CO-SEGREGATION
Template DNA strand co-segregation has been observed in stem
cells across numerous tissue types, but the underlying molecu-
lar mechanism(s) regulating this process has remained elusive. In
order to decipher how template chromosomes are asymmetrically
segregated during cell division, one must identify what “marks”
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the newer and older DNA strands, what cellular machinery rec-
ognizes those marks and finally, what process actively recruits
the chromosomes bearing those marks to one daughter cell. The
Tajbakhsh group speculated that the mother centrosome might
anchor certain sister chromatids to the polarized cortex (35).
How the kinetochore might relay information to the centrosome
and cell cortex via the mitotic spindle to mediate asymmetric
chromosome segregation is still unsolved.
Much of the effort to identify the molecular mechanisms
responsible for a cell’s decision to co-segregate its template DNA
strands has been pioneered by the Sherley group. Rambhatla et al.
demonstrated that template DNA co-segregation was induced by
p53 and required the down-regulation of an enzyme essential
for guanine nucleotide biosynthesis, IMP dehydrogenase (36).
Perhaps the mechanism by which p53 regulates template DNA
strand co-segregation is linked to the concentration of gua-
nine nucleotides, although it could also be linked to one or
more of many other cellular functions regulated by guanine
nucleotides, such as signal transduction, glycoprotein synthe-
sis, or energy transfer. It was not clear if down-regulation of
IMP dehydrogenases was sufficient for p53-induced template
DNA co-segregation, or if one or more of the numerous p53-
regulated genes were also key modulators of template DNA strand
co-segregation.
Sherley’s group later discovered that the template DNA strands
harbor more of the histone H2A variant H2A.Z that is“uncloaked”,
meaning that it is more detectable by immunofluorescence (37).
They more recently reported that the template DNA strands had
a higher content of 5-hydroxymethylcytosine (5hmC) than the
newer DNA strands, which is an intermediate during DNA methy-
lation (38). Although 5hmC, or a unique protein complex that
binds 5hmC in stem cells, could possibly be the elusive “mark” of
template DNA strands, differences in DNA demethylation between
the two daughter cells of an asymmetric stem cell division are
also consistent with the idea that the template DNA strand co-
segregation dictates cell fate via a differential regulation of gene
expression in the two daughter cells. Klar’s group discovered addi-
tional clues that could underlie the mechanisms of template DNA
co-segregation. They found that in S. pombe and Schizosaccha-
romyces japonicas yeast that a DNA strand-specific epigenetic
imprint at the mating locus initiates a recombination event, which
is required for cellular differentiation (16, 39). In their system,
an inherent chirality of the double-helical structure of DNA was
needed to achieve ACD. They later provided evidence for this dur-
ing mouse development (13). An intriguing question is whether
a similar epigenetic mechanism is conserved on a global level in
multicellular organisms to dictate different cell fate potentials of
the daughter cells.
Wnt PATHWAY
Additional clues about the mechanisms driving template DNA
strand co-segregation have emerged from studies of stem-cell sig-
naling pathways that are either associated with or actively affect
the balance of ACD and template DNA strand co-segregation.
Wnt signaling is a key stem cell signaling pathway implicated
in self-renewal of both normal stem cells and CSCs, as well as
epithelial–mesenchymal transition in cancer (40). Inhibition of
Wnt signaling decreased the frequency of template DNA co-
segregation in gastrointestinal cancer cell lines (21). This work
was challenged in a separate study in which random segregation
of template DNA in colorectal CSCs was induced by Wnt signaling
(41). It would be interesting to test if Wnt inhibition or activation
reduces template DNA co-segregation by increasing symmetric
divisions of non-stem cells, or increasing symmetric self-renewing
divisions within the stem cell population, respectively. Although
it was uncertain whether Wnt signaling played a direct role in
regulating template DNA co-segregation, or if one of the many
pathways modulated by Wnt/β-catenin signaling were responsi-
ble, these studies demonstrated that factors in addition to p53 or
IMP dehydrogenase may directly modulate co-segregation of tem-
plate DNA, and particularly, genes within signaling pathways that
direct stem cell fate.
NOTCH PATHWAY
The most extensively studied pathway associated with template
DNA co-segregation is the Notch signaling pathway. Notch is a
developmental and adult stem/progenitor cell transcription factor
that regulates self-renewal and differentiation in a highly cell-type
and context-specific manner (42). Notch signaling is dysregulated
across numerous types of cancer and plays a key role in regulating
CSC self-renewal (43). The Notch pathway directly participates in
ACD across several cell types in lower organisms such as Drosopila
and C. elegans, as well as in mice and human beings (1). For exam-
ple, in Drosophila neuroblasts the Notch inhibitor Numb is inher-
ited by the daughter cell that is destined to undergo differentiation
(1, 44). When Numb is mutated, the neuroblasts hyperproliferate
and form a tumor-like phenotype (45, 46). Notch dysregulation
is also an active participant during the development of cancer in
mouse models (47–49), though whether the role of Notch in car-
cinogenesis involves shifting the mode of CSC divisions toward
excessive symmetric self-renewal has not been established.
Notch signaling has been linked to template DNA co-
segregation. One example has been demonstrated in muscle satel-
lite stem cells. Satellite cells self-renew and provide the generation
of myoblasts that are needed for skeletal muscle homeostasis and
repair. Muscle satellite stem cells co-segregate their template DNA
strands (50, 51) and the daughter stem cells that inherit the tem-
plate DNA preferentially inherit Numb (50). In colon CSCs, an
increase in Notch mRNA levels caused by knockdown of miR34a
increases symmetric self-renewing divisions and decreases ACDs
(52). It is still unclear whether Notch signaling is a cellular con-
stituent that is asymmetrically segregated in parallel with but
independent from template strand co-segregation, or if Notch
signaling is a regulator or effector of template DNA co-segregation.
CONCLUSION
It has been nearly 50 years since the first discovery of template
DNA co-segregation. Though it has been observed across numer-
ous species, normal tissue, and cancer, we have still only scratched
the surface toward elucidating the purpose for conserving template
DNA strands in one daughter cell and the mechanisms regulat-
ing the process. Consistent with the notion that the immortal
DNA strand hypothesis does not fully capture why stem cells
asymmetrically segregate their template DNA, there has been
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increasing evidence that the mother cell controls gene expression
in the daughter cells through asymmetric segregation of epigenetic
marks. With recent advances in genomics, chromosome-imaging
technologies, and genetically modified model organisms [reviewed
in Ref. (10)], the outlook for success in further answering these
daunting questions is bright. Elucidating why and how template
DNA strands are co-segregated is a fundamental aim in basic and
translational science that spans many disciplines, and the impli-
cations could be profound. If we can manipulate self-renewal of
stem cells, this could result in lucrative applications for directing
self-renewal and differentiation for regenerative medicine, revers-
ing degenerative diseases, as well as therapeutic interventions of
cancer.
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